Substance P immunoreactivity increases following human traumatic brain injury

Acta Neurochirurgica, Supplementum

Volumn , Issue 106, 2009, Pages 211-216

  Zacest, Andrew C ^a   Vink, Robert ^c   Manavis, Jim ^b   Sarvestani, Ghafar T ^b   Blumbergs, Peter C ^c  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b INSTITUTE OF MEDICAL AND VETERINARY SCIENCE   (Australia)

^c NONE

Author keywords

brain swelling; edema; neurogenic inflammation; Neurotrauma; substance P; tachykinin

Indexed keywords

AMYLOID PRECURSOR PROTEIN; NEUROPEPTIDE; SUBSTANCE P;

ADOLESCENT; ADULT; AGED; ASTROCYTE; AXONAL INJURY; BRAIN CELL; BRAIN CONTUSION; BRAIN CORTEX; BRAIN ISCHEMIA; CHILD; CLINICAL ARTICLE; CONFERENCE PAPER; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOREACTIVITY; MALE; NEUROLOGIC EXAMINATION; NEUROPATHOLOGY; PRESCHOOL CHILD; PROTEIN LOCALIZATION; PROTEIN SECRETION; SCHOOL CHILD; SUBARACHNOID HEMORRHAGE; SUBDURAL HEMATOMA; TRAUMATIC BRAIN INJURY;

EID: 72949105921     PISSN: 00651419     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-3-211-98811-4_39     Document Type: Conference Paper

References (28)

1. Black PH (2002) Stress and the inflammatory response: a review of neurogenic inflammation. Brain Behav Immun 16:622-653
2. Blumbergs PC, Scott G, Manavis J, Wainwright H, Simpson DA, McLean AJ (1995) Topography of axonal injury as defined by amyloid precursor protein and the sector scoring method in mild and severe closed head injury. J Neurotrauma 12:565-572
3. Brimijoin S, Lundberg JM, Brodin E, Hokfelt T, Nilsson G (1980) Axonal transport of substance P in the vagus and sciatic nerves of the guinea pig. Brain Res 191:443-457
4. Brown JL, Liu H, Maggio JE, Vigna SR, Mantyh PW, Basbaum AI (1995) Morphological characterization of substance P receptorimmunoreactive neurons in the rat spinal cord and trigeminal nucleus caudalis. J Comp Neurol 356:327-344
5. Bruno G, Tega F, Bruno A, Graf U, Corelli F, Molfetta R, Barucco M (2003) The role of substance P in cerebral ischemia. Int J Immunopathol Pharmacol 16:67-72
6. Castro-Obregon S, Del Rio G, Chen SF, Swanson RA, Frankowski H, Rao RV, Stoka V, Vesce S, Nicholls DG, Bredesen DE (2002) A ligand-receptor pair that triggers a non-apoptotic form of programmed cell death. Cell Death Differ 9:807-817
7. Del Fiacco M, Dessi ML, Atzori MG, Levanti MC (1983) Substance P in the human brainstem. Preliminary results of its immunohistochemical localization. Brain Res 264:142-147
8. Dimitriadou V, Buzzi MG, Theoharides TC, Moskowitz MA (1992) Ultrastructural evidence for neurogenically mediated changes in blood vessels of the rat dura mater and tongue following antidromic trigeminal stimulation. Neuroscience 48:187-203
9. Donkin JJ, Turner RJ, Hassan I, Vink R (2007) Substance P in traumatic brain injury. Prog Brain Res 161:97-109
10. Eng LF, Ghirnikar RS, Lee YL (2000) Glial fibrillary acidic protein: GFAP-thirty-one years (1969-2000). Neurochem Res 25: 1439-1451
11. Ghabriel MN, Lu MX, Leigh C, Cheung WC, Allt G (1999) Substance P-induced enhanced permeability of dura mater microvessels is accompanied by pronounced ultrastructural changes, but is not dependent on the density of endothelial cell anionic sites. Acta Neuropathol (Berl) 97:297-305
12. Hokfelt T, Meyerson B, Nilsson G, Pernow B, Sachs C (1976) Immunohistochemical evidence for substance P-containing nerve endings in the human cortex. Brain Res 104:181-186
13. Kennedy PG, Rodgers J, Jennings FW, Murray M, Leeman SE, Burke JM (1997) A substance P antagonist, RP-67, 580, ameliorates a mouse meningoencephalitic response to Trypanosoma brucei brucei. Proc Natl Acad Sci USA 94:4167-4170
14. Kostyk SK, Kowall NW, Hauser SL (1989) Substance P immunoreactive astrocytes are present in multiple sclerosis plaques. Brain Res 504:284-288
15. Lin RC (1995) Reactive astrocytes express substance-P immunoreactivity in the adult forebrain after injury. Neuroreport 7:310-312
16. Liu H, Mazarati AM, Katsumori H, Sankar R, Wasterlain CG (1999) Substance P is expressed in hippocampal principal neurons during status epilepticus and plays a critical role in the maintenance of status epilepticus. Proc Natl Acad Sci USA 96:5286-5291
17. Maggi CA (1995) Tachykinins and calcitonin gene-related peptide (CGRP) as co-transmitters released from peripheral endings of sensory nerves. Prog Neurobiol 45:1-98
18. Mantyh PW, Johnson DJ, Boehmer CG, Catton MD, Vinters HV, Maggio JE, Too HP, Vigna SR (1989) Substance P receptor binding sites are expressed by glia in vivo after neuronal injury. Proc Natl Acad Sci USA 86:5193-5197
19. Nakagawa N, Sano H, Iwamoto I (1995) Substance P induces the expression of intercellular adhesion molecule-1 on vascular endothelial cells and enhances neutrophil transendothelial migration. Peptides 16:721-725
20. Newbold P, Brain SD (1995) An investigation into the mechanism of capsaicin-induced oedema in rabbit skin. Br J Pharmacol 114:570-577
21. Nimmo AJ, Cernak I, Heath DL, Hu X, Bennett CJ, Vink R (2004) Neurogenic inflammation is associated with development of edema and functional deficits following traumatic brain injury in rats. Neuropeptides 38:40-47
22. Ohlen A, Thureson-Klein A, Lindbom L, Persson MG, Hedqvist P (1989) Substance P activates leukocytes and platelets in rabbit microvessels. Blood Vessels 26:84-94
23. Reilly PL (2001) Brain injury: the pathophysiology of the first hours. 'Talk and Die revisited'. J Clin Neurosci 8:398-403
24. Stjernholm Y, Sennstrom M, Granstom L, Ekman G, Johansson O (1999) Protein gene product 9.5 - immunoreactive nerve fibers and cells in human cervix of late pregnant, postpartal and non-pregnant women. Acta Obstet Gynecol Scand 78:299-304
25. Stumm R, Culmsee C, Schafer MK, Krieglstein J, Weihe E (2001) Adaptive plasticity in tachykinin and tachykinin receptor expression after focal cerebral ischemia is differentially linked to gabaergic and glutamatergic cerebrocortical circuits and cerebrovenular endothelium. J Neurosci 21:798-811
26. Turner RJ, Blumbergs PC, Sims NR, Helps SC, Rodgers KM, Vink R (2006) Increased substance P immunoreactivity after reversible ischemic stroke. Acta Neurochir Suppl 96:263-266
27. Zachrisson O, Lindefors N, Brene S (1998) A tachykinin NK1 receptor antagonist, CP-122, 721-1, attenuates kainic acid-induced seizure activity. Brain Res Mol Brain Res 60:291-295
28. Ziche M, Morbidelli L, Geppetti P, Maggi CA, Dolara P (1991) Substance P induces migration of capillary endothelial cells: a novel NK-1 selective receptor mediated activity. Life Sci 48:PL7-11